A Randomized Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients with Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects

IRB/UVA Tracking #
20327
Contact
Julio Torres
Contact Email
Contact Phone
+1 .434.4-98
Phase
II
Primary purpose
Treatment
Cancer PI
Robert Dreicer
Status
OPEN TO ACCRUAL